Cytokine & Growth Factor Reviews

Cytokine & Growth Factor Reviews is a bimonthly peer-reviewed review journal published by Elsevier Ltd since 1996, continuing Progress in Growth Factor Research and covering cytokines and growth factors from signalling to clinical medicine, with a 2025 Journal Impact Factor of 13.4（Cytokine & Growth Factor Reviews）是（Elsevier Ltd）自 1996 年起出版的双月刊同行评审综述期刊，延续（Progress in Growth Factor Research），内容覆盖从信号转导到临床医学的细胞因子与生长因子研究，2025 年影响因子为 13.4。

Scope

• It publishes critical reviews, state-of-the-art reviews, letters to the editor and meeting reviews该刊发表评论性综述、最新进展综述、致编辑信与会议综述。
• Articles may be invited by the editor or submitted unsolicited as surveys, mini reviews or perspectives文章既可应编辑邀请撰写，也可作为综述、小型综述或观点文章自由投稿。
• The journal is devoted to important advances in growth factor and cytokine research该刊专注生长因子与细胞因子研究的重要进展。
• Major emphasis falls on multidisciplinary significance in signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine重点强调其在信号转导、细胞生长与分化、胚胎发育、免疫学、肿瘤发生与临床医学中的多学科意义。
• Reviews often examine cytokine receptors and the signalling pathways they trigger综述常探讨细胞因子受体及其启动的信号通路。^[1]
• Clinical and translational themes such as the cytokine storm in COVID-19 also feature among its reviews临床与转化主题（如新冠中的细胞因子风暴）也在其综述之列。^[2]

History

• The journal began in June 1996 with volume 7, continuing Progress in Growth Factor Research该刊于 1996 年 6 月以第 7 卷创刊，延续（Progress in Growth Factor Research）。^[3]
• It is issued bimonthly, with six volumes each year, reaching volume 92 in 2026该刊双月出版，每年 6 卷，2026 年出至第 92 卷。
• It is published by Elsevier Ltd, which holds all rights to the content由（Elsevier Ltd）出版并持有全部权利。
• There are no page charges for authors该刊不向作者收取版面费。
• Its impact factor was 7.638 in 2021, 17.66 in 2022, 11.8 in 2024 and 13.4 in 2025其影响因子 2021 年为 7.638，2022 年为 17.66，2024 年为 11.8，2025 年为 13.4。
• It ranks 21st among 328 journals in the Journal Citation Reports biochemistry and molecular biology category在（Journal Citation Reports）的生物化学与分子生物学类别 328 种期刊中排名第 21。
• Publication is hybrid, with subscription publishing free of charge or open access for 4860 US dollars出版为混合模式，可按订阅模式免费发表，或支付 4860 美元开放获取。

Editors

• The Editor is John Hiscott of the Pasteur Laboratories, Istituto Pasteur Italia, in Rome主编为罗马（Istituto Pasteur Italia）帕斯特实验室的（John Hiscott）。
• The editorial board includes Guido Kroemer of the Cordeliers Research Centre in Paris编委包括巴黎（Cordeliers Research Centre）的（Guido Kroemer）。
• Interleukin-6 specialists on the board include Stefan Rose-John of Kiel University and Christoph Garbers of Hannover Medical School白细胞介素-6 领域的编委包括（Kiel University）的（Stefan Rose-John）与（Hannover Medical School）的（Christoph Garbers）。
• Viral immunology is represented by Adolfo Garcia-Sastre of the Icahn School of Medicine at Mount Sinai and Michaela Gack of Cleveland Clinic病毒免疫学方向由（Icahn School of Medicine at Mount Sinai）的（Adolfo Garcia-Sastre）与（Cleveland Clinic）的（Michaela Gack）代表。
• Members based in China include Hong-Bing Shu of Wuhan University, Shao-Cong Sun of the Chinese Institutes for Medical Research and Qingqing Wang of Zhejiang University在中国任职的编委包括（Wuhan University）的（Hong-Bing Shu）、（Chinese Institutes for Medical Research）的（Shao-Cong Sun）与（Zhejiang University）的（Qingqing Wang）。
• The journal pledges to improve gender, geographic, racial and age diversity on its editorial team该刊承诺在编委团队的性别、地域、族裔与年龄维度上提升多样性。